Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ CD11c Monoclonal Antibody (CBR-p150/4G1)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA516613
Description
For FACS analysis, use 10 μL of the suggested working dilution to label 1x10^6 cells in 100 μL.
CD11, along with CD18, form a heterodimer adhesion molecule. In particular, CD11 is composed of CD11a, CD11b and CD11c. CD11a is a leukocyte marker that is expressed in B and T lymphocytes, macrophages, monocytes, neutrophils, basophils and eosinophils. CD11b is primarily expressed by monocytes, macrophages, natural killer cells, some B and T-cells, and granulocytes. CD11c is expressed in monocytes, macrophages, natural killer cells, some granulocytes and less so in a subset of lymphocytes.
Specifications
CD11c | |
Monoclonal | |
1 mg/mL | |
PBS with no preservative | |
P20702 | |
Itgax | |
Recombinant human CD11c. | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG2a |
Flow Cytometry, Functional Assay, Immunohistochemistry (Frozen) | |
CBR-p150/4G1 | |
Unconjugated | |
Itgax | |
AI449405; CD11 antigen-like family member C; CD11c; CD11C (p150) alpha polypeptide; complement component 3 receptor 4 subunit; complement receptor 4; Cr4; integrin alpha X; integrin alpha-X; integrin aX; integrin subunit alpha X; integrin, alpha X; integrin, alpha X (antigen CD11C (p150), alpha polypeptide); integrin, alpha X (complement component 3 receptor 4 subunit); Itgax; Leu M5; leu M5, alpha subunit; leukocyte adhesion glycoprotein p150,95 alpha chain; Leukocyte adhesion receptor p150,95; leukocyte surface antigen p150,95, alpha subunit; myeloid membrane antigen, alpha subunit; N418; p150 95 integrin alpha chain; RGD1561123; SLEB6 | |
Mouse | |
Protein A | |
RUO | |
3687 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction